Monthly Archives: October 2019
Our 2020 BCGP and BCACP study materials have been updated and are ready to go! As with our BCPS and BCMTMS content, I wanted to give a special discount as well as the opportunity for a FREE Audiobook! (See the end of the post for details on the discount!) Here’s some feedback from previous BCGP […]
Read More
In this case scenario below, I discuss the mirabegron tamoxifen interaction and how it can impact patient safety. KS is a 61-year-old female who presents with worsening urinary frequency. She has been diagnosed with overactive bladder and place on oxybutynin. She was taking 5 mg daily and states that the dry mouth from the medication […]
Read MoreOur 2020 BCGP and BCACP study materials have been updated and are ready to go! As with our BCPS and BCMTMS content, I wanted to give a special discount as well as the opportunity for a FREE Audiobook! (See the end of the post for details on the discount!) Here’s some feedback from previous BCGP […]
Read More
When the NOACs (sometimes referred to as DOACs) first came out they were heavily promoted as having fewer drug interactions compared to warfarin. This is true, but please remember that “fewer drug interactions” doesn’t mean “no drug interactions”! Here’s a scenario of the carbamazepine apixaban interaction and some potential strategies to manage it. A 72-year-old […]
Read More
In an update from a previous post, the CPJE cheating scandal rolls on. Over 1,000 pharmacy students had their scores invalidated. This means that they have to make plans to retake the CPJE exam. In their most recent update on the CPJE cheating scandal, the California Board of Pharmacy has set aside two dates (November […]
Read More